A randomised, double-blind, placebo-controlled, two-part study to evaluate the pharmacokinetics, safety and tolerability, and preliminary efficacy of two dose levels of golexanolone in subjects with primary biliary cholangitis, fatigue, and cognitive dysfunction (UCAB-CT-05)

Principal Investigator

Dr Emma Culver

Contact us

Email: ouh-tr.ctfresearch@nhs.net

IRAS number

1003871